Product Information

ERYTHROMYCIN-BENZOYL GEL is a generic product labeled by Rising Pharma Holdings Inc., priced at $1.6013 per GM under NDC 64980032801. Its NADAC has been published 506 times since Dec 14, 2016.

FDA first approved this application on Sep 18, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ERYTHROMYCIN-BENZOYL GEL

Erythromycin and Benzoyl Peroxide
$1.6013per GM

Strength

50; 30 mg/g; mg/g

NDC

64980032801

Classification

Generic

Dosage Form

GEL

Route

TOPICAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA065385

FDA Approved

9/18/2015

TE Code

AB

On Market Since

10/18/2016

Pharmacological Classes

Decreased Sebaceous Gland Activity
Macrolide Antimicrobial
Macrolide
Macrolides

Price Statistics

The NADAC for ERYTHROMYCIN-BENZOYL GEL has been published 506 times since Dec 14, 2016, and over the history we have for it it has declined 73.2%. The table below summarizes its recorded NADAC range and movement.

Current price$1.6013 per GM
All-time high$6.0413 (Jul 12, 2017)
All-time low$1.3020 (May 22, 2024)
52-week high$2.0094
52-week low$1.4808
Median price$2.2885
Average price$2.7805
Largest weekly change+77.0% (Jun 23, 2021)
Weeks tracked506
Tracking sinceDec 14, 2016

Price History

1W

-9.4%

1M

-9.4%

3M

-20.3%

6M

-3.4%

1Y

-0.0%

3Y

-7.0%

5Y

-21.1%

All

-73.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 34%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of ERYTHROMYCIN-BENZOYL GEL?

The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN-BENZOYL GEL, manufactured by Rising Pharma Holdings Inc., is $1.6013 per GM (NDC 64980032801), effective Aug 19, 2026.

How has the price of ERYTHROMYCIN-BENZOYL GEL changed over time?

Over the history we have for it, the NADAC for ERYTHROMYCIN-BENZOYL GEL has declined 73.2%. It has been tracked across 506 weekly CMS publications since Dec 14, 2016.

What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN-BENZOYL GEL?

Since Dec 14, 2016, the NADAC for ERYTHROMYCIN-BENZOYL GEL has ranged from a low of $1.3020 (May 22, 2024) to a high of $6.0413 (Jul 12, 2017), with a median of $2.2885 per GM.

Are there cheaper alternatives to ERYTHROMYCIN-BENZOYL GEL?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ERYTHROMYCIN-BENZOYL GEL, is $1.0520 per GM — about 34% below ERYTHROMYCIN-BENZOYL GEL.

Who manufactures ERYTHROMYCIN-BENZOYL GEL?

ERYTHROMYCIN-BENZOYL GEL (NDC 64980032801) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.